NORTHERN TRUST CORP - KERYX BIOPHARMACEUTICALS INC ownership

KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 131 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 1.05 and the average weighting 0.1%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of KERYX BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2018$4,250,000
-5.0%
1,250,239
+5.0%
0.00%0.0%
Q2 2018$4,476,000
+0.1%
1,190,143
+8.8%
0.00%0.0%
Q1 2018$4,473,000
-12.9%
1,093,563
-0.9%
0.00%0.0%
Q4 2017$5,134,000
-36.1%
1,104,048
-2.4%
0.00%
-50.0%
Q3 2017$8,030,000
+1.9%
1,130,921
+3.8%
0.00%0.0%
Q2 2017$7,881,000
+25.5%
1,089,860
+6.9%
0.00%0.0%
Q1 2017$6,279,000
+11.9%
1,019,440
+6.5%
0.00%0.0%
Q4 2016$5,609,000
+10.9%
957,142
+0.5%
0.00%0.0%
Q3 2016$5,057,000
-20.0%
952,216
-0.2%
0.00%0.0%
Q2 2016$6,318,000
+15.6%
954,397
-18.5%
0.00%0.0%
Q1 2016$5,467,000
-6.6%
1,170,527
+1.0%
0.00%0.0%
Q4 2015$5,855,000
+47.1%
1,159,418
+2.5%
0.00%
+100.0%
Q3 2015$3,981,000
-63.7%
1,131,074
+2.8%
0.00%
-66.7%
Q2 2015$10,982,000
-22.5%
1,100,484
-1.2%
0.00%
-25.0%
Q1 2015$14,178,000
-0.5%
1,113,724
+10.6%
0.00%0.0%
Q4 2014$14,254,000
-0.5%
1,007,373
-3.3%
0.00%0.0%
Q3 2014$14,324,000
-10.8%
1,041,742
-0.2%
0.00%
-20.0%
Q2 2014$16,054,000
-19.4%
1,043,831
-10.7%
0.01%
-16.7%
Q1 2014$19,912,000
+32.1%
1,168,578
+0.4%
0.01%
+20.0%
Q4 2013$15,068,000
+31.3%
1,163,543
+2.3%
0.01%
+25.0%
Q3 2013$11,478,000
+34.4%
1,137,452
-0.5%
0.00%
+33.3%
Q2 2013$8,540,0001,143,3500.00%
Other shareholders
KERYX BIOPHARMACEUTICALS INC shareholders Q4 2017
NameSharesValueWeighting ↓
VHCP Management, LLC 700,273$10,770,0005.76%
HARVEY CAPITAL MANAGEMENT INC 932,400$14,340,0005.13%
Camber Capital Management LP 3,000,000$46,140,0003.02%
Baupost Group 10,539,986$162,105,0002.64%
SECTORAL ASSET MANAGEMENT INC 3,741,656$57,547,0002.44%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,884,409$59,742,0002.40%
Knoll Capital Management, LLC 200,000$3,076,0001.37%
DAFNA Capital Management LLC 92,400$1,421,0001.35%
NORTHPOINTE CAPITAL LLC 892,011$13,719,0001.32%
Rhenman & Partners Asset Management AB 240,000$3,691,0001.10%
View complete list of KERYX BIOPHARMACEUTICALS INC shareholders